BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 15034237)

  • 1. Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.
    Lucijanic M; Krecak I; Galusic D; Holik H; Perisa V; Moric Peric M; Zekanovic I; Budimir J; Lekovic D; Kusec R
    Ann Hematol; 2024 Jun; 103(6):2157-2159. PubMed ID: 38652241
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Megakaryocytes as regulators of tumor microenvironments.
    Migliaccio AR; Balduini A; Zhan H
    Front Oncol; 2022; 12():1090658. PubMed ID: 36505825
    [No Abstract]   [Full Text] [Related]  

  • 3. Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics.
    Nann D; Fend F
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO classification of myeloproliferative neoplasms (MPN): A critical update.
    Kvasnicka HM
    Curr Hematol Malig Rep; 2013 Dec; 8(4):333-41. PubMed ID: 24146204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of plasma cell dyscrasia with prefibrotic stage of primary myelofibrosis: a case report.
    Tsirakis G; Kanellou P; Kaparou M; Passam A; Zampoulaki A; Stylianou K; Alexandrakis MG
    ISRN Hematol; 2011; 2011():404057. PubMed ID: 22084697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
    Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
    Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status.
    Bock O; Neuse J; Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H
    Am J Pathol; 2006 Aug; 169(2):471-81. PubMed ID: 16877349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefibrotic chronic idiopathic myelofibrosis--a diagnostic enigma?
    Thiele J; Kvasnicka HM
    Acta Haematol; 2004; 111(3):155-9. PubMed ID: 15034237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopathologic findings in chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Semin Oncol; 2005 Aug; 32(4):380-94. PubMed ID: 16202684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
    Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H
    Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.